Avyuct Information

We are entering the 'Distal Era' of stroke care. Following the clinical success of distal catheters at #ISC26, the challenge has shifted from surgical access to diagnostic precision. I founded Avyuct to bridge the 'Distal Gap' that standard LVO-focused AI ignores. While incumbent systems prioritize large vessel signals, Avyuct specializes in the high-noise, high-stakes environment of the M2-M4 segments (1.5mm–2.0mm vasculature). Our Clinical Moat is built on three pillars: Sub-Threshold Mastery: Proprietary training on expert-adjudicated distal stroke datasets. Edge-Native Deployment: Moving AI from the cloud to the scanner console for 'zero-latency' triage. Institutional Validation: Partnering with the leading institutions and universities and the NIH StrokeNet ecosystem to define the new standard for distal sensitivity. We aren't just finding clots; we are providing the vision needed to navigate the next frontier of neuro-intervention."